Rxo (RXO) Operating Leases (2021 - 2026)

Rxo (RXO) has reported Operating Leases for 6 consecutive years, with $167.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 16.92% year-over-year to $167.0 million; the trailing twelve-month figure through Jun 2026 stood at $167.0 million (down 16.92% YoY), and the FY2025 full-year result was $191.0 million, down 35.47% from the prior year.
• Operating Leases fell to $167.0 million in Q2 2026 per RXO's latest filing, from $182.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $296.0 million in Q4 2024 and bottomed at $109.0 million in Q1 2023.
• Historically, Operating Leases has averaged $177.7 million across 5 years, with a median of $174.5 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Operating Leases soared 108.8% in 2024, then sank 35.47% in 2025.
• Over 5 years, Operating Leases stood at $162.0 million in 2022, then increased by 22.84% to $199.0 million in 2023, then soared by 48.74% to $296.0 million in 2024, then tumbled by 35.47% to $191.0 million in 2025, then dropped by 12.57% to $167.0 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $167.0 million, $182.0 million, and $191.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.